A phase I study of SER130 (interleukin-4 partial receptor agonists) for the treatment of Acute Myocardial Infarction.
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2016
At a glance
- Drugs Interleukin 4 receptor agonists (Primary)
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 14 Jan 2016 New trial record